Skip to content

Clinical trials

Thrombocythemia, Essential trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Germany Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20053
20102
20134
20144
20151
20181
20191
20201
20211
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting7
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Incyte Corporation4
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
Italfarmaco2
Merck Sharp & Dohme LLC2
Shire2
Sierra Oncology LLC - a GSK company2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential28
Primary Myelofibrosis17
Polycythemia Vera16
Myeloproliferative Disorders15
Hematologic Diseases6
Bone Marrow Diseases5
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Neoplasms5
Blast Crisis4

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.